West German Study Group

This study is for people with early-stage triple-negative breast cancer, a type known for being aggressive. It compares two drug combinations given before surgery to see if they can effectively eliminate the cancer while being easier to tolerate than standard chemotherapy. The tr…

This study is testing if adding the drug capivasertib to standard hormone therapy can help people with a specific type of advanced breast cancer stay on their treatment longer and maintain their quality of life. It is for adults whose cancer has continued to grow despite prior ho…

This study is a long-term registry that will follow 1,470 premenopausal women with early-stage, hormone-sensitive breast cancer for up to 10 years. It aims to understand how different standard treatment choices—like hormone therapy with or without ovarian suppression, and chemoth…